Tang Capital Management LLC Tcr2 Therapeutics Inc. Transaction History

Tang Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.0 - $1.62 $660,798 - $1.07 Million	660,798 Added 24.13%	3,399,745 $5.1 Million
Q4 2022 Feb 14, 2023	SELL	$0.83 - $1.44 $749,206 - $1.3 Million	-902,659 Reduced 24.79%	2,738,947 $2.74 Million
Q2 2022 Aug 15, 2022	BUY	$2.11 - $2.94 $1.35 Million - $1.89 Million	641,606 Added 21.39%	3,641,606 $10.6 Million
Q1 2022 May 16, 2022	BUY	$2.4 - $4.71 $7.2 Million - $14.1 Million	3,000,000 New	3,000,000 $8.28 Million

Ticker TCRR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,606,400
Description
TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical tria...

Get notified when there are updates to the investment portfolio of Tang Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tang Capital Management LLC with notifications on news.